Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking

Wenkai Zhou1,2, Yisheng Feng2, Chengzhong Lin2,3

  • 1Department of Oral and Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.

Insights

A novel long non-coding RNA, DUXAP9, promotes oral squamous cell carcinoma (OSCC) progression by stabilizing EZH2. Targeting DUXAP9 may offer a new therapeutic strategy for OSCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) are crucial in cancer, but their roles in oral squamous cell carcinoma (OSCC) are not fully elucidated.
  • Understanding lncRNA functions is vital for developing novel OSCC therapies.

Purpose of the Study:

  • To identify and characterize a novel lncRNA, DUXAP9, in OSCC.
  • To investigate the molecular mechanisms underlying DUXAP9's role in OSCC progression.
  • To evaluate DUXAP9 as a potential therapeutic target for OSCC.

Main Methods:

  • Identification and expression analysis of DUXAP9 in OSCC tissues and cell lines.
  • In vitro and in vivo experiments to assess the functional role of DUXAP9 in OSCC cell proliferation, migration, and invasion.
  • Investigation of DUXAP9's interaction with EZH2 and its downstream targets.
  • Analysis of the correlation between DUXAP9 expression and clinical parameters in OSCC patients.

Main Results:

  • DUXAP9 is highly expressed in OSCC and its high expression correlates with advanced clinical stage, lymph node metastasis, and poor patient survival.
  • Overexpression of DUXAP9 promotes OSCC cell proliferation, migration, invasion, and tumor growth, while its knockdown suppresses these processes.
  • DUXAP9 stabilizes EZH2 by inhibiting its phosphorylation and subsequent degradation, thereby promoting OSCC progression in an EZH2-dependent manner.
  • Yin Yang 1 (YY1) was identified as a transcriptional activator of DUXAP9.

Conclusions:

  • DUXAP9 is a novel oncogenic lncRNA that drives OSCC progression through the DUXAP9/EZH2 axis.
  • DUXAP9 expression levels are associated with poor prognosis in OSCC patients.
  • DUXAP9 represents a promising therapeutic target for oral squamous cell carcinoma.

Related Concept Videos

Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K